Parthenon Therapeutics
0 followers
Parthenon Therapeutics is inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment (TME). The interplay between cancer cells and their surrounding microenvironment is relevant in drug development as many cancers use the TME to build barriers that shield immune syste... Read more
Org chart
Laurent Audoly
CEO & Co-Founder
Laurent Audoly
Collapse
Joseph Paul Eder
Chief Medical Officer
Peter Cincotta
Controller
Susan G. MacDonald
VP, R&D Strategy & Project Management
Thomas Schürpf
VP & Head, Development
Tom McCaughtry
VP & Head, Research
Yan Qin
Principal Scientist, Cancer Biology
Amy Mueller
Principal Scientist, Bioinformatics
Ryan Newton
Principal Scientist, Tumor Microenvironment
Lisa Gaynes
Head, Clinical Strategic Alliances
Heather Condurso
Director, Biotherapeutics
Xinwei Sher
Director, Data Science
Marianna Murphy
Operations Coordinator
Fredrick Gootkind
Senior Associate Scientist, Bioinformatics & Data Science
Ziyin Wang
Senior Associate Scientist, Data Science
Joshua Merritt
Senior Associate Scientist, Tumor Immunology
Paula Bucko
Scientist, Tumor Biology
Irena Lerentracht Webster
Svp, Development And Operations
Christopher O’donnell
Partner Pfizer Ventures
